产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 |
CAS No. |
765259-05-0 |
|---|---|
中文名称 |
N-芴甲氧羰基-L-丙氨酸-13C3 |
英文名称 |
Fmoc-Ala-OH-13C3 |
标准英文名 |
(((9H-fluoren-9-yl)methoxy)carbonyl)-L-alanine-13C3 |
分子式 |
C18H17NO4 |
分子量 |
314.31 |
精确分子量 |
314.13 |
SMILES |
[13CH3][13C@@H]([13C](O)=O)NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O |
标准SMILES |
[13CH3][13C@H](NC(=O)OCC1C2C=CC=CC=2C2C=CC=CC=21)[13C](O)=O |
用途 |
Fmoc-leucine is a selective PPARγ modulator that improves insulin sensitivity in normal, diet-induced glucose-intolerant, and diabetic db/db mice; it exhibits lower adipogenic activity compared to rosiglitazone while achieving a similar maximal effect despite lower PPARγ activation potency. |
InChIKey |
QWXZOFZKSQXPDC-XZYMTLJFSA-N |
|
|
评论 |
|---|